Generic Drugmakers Struggle Despite U.S. Push for Copycats

(Bloomberg) -- Generic drugmakers are being crushed by the very forces that the Trump administration is counting on to drive down prescription costs.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.